ReviewJournal of the Korean Society of Radiology2026
Role of Cardiac CT in the Evaluation of Valvular Heart Disease.
Review in Journal of the Korean Society of Radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Mitral Stenosis in the Multimodality Imaging Era: Pitfalls, Stress Echocardiography, and Integrated Therapeutic Assessment.Diagnostics (Basel, Switzerland) · 2026Review
- [Preface to the Special Issue on 'Pragmatic Cardiovascular Imaging'].Journal of the Korean Society of Radiology · 2026Article
- Contrast-enhanced chest computed tomography in acute heart failure: a narrative review of imaging clues to precipitating factors and underlying cardiac disease.Journal of Yeungnam medical science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiac CT has become an essential imaging modality in the diagnostic and therapeutic workflow for valvular heart disease (VHD), particularly in the era of transcatheter and minimally invasive valve therapies. The existing guidelines emphasize cardiac CT infrastructure and expertise as core requirements for both primary and comprehensive valve centers. Advances in CT acquisition and image reconstruction allow precise evaluation of valvular morphology, motion, and calcification, supporting accurate disease-severity grading and procedural planning. In comparison with echocardiography, cardiac CT provides superior spatial resolution and is less affected by acoustic shadowing from heavy calcification or prosthetic materials, making it especially valuable in complex or inconclusive cases. This review summarizes the CT scanning protocols and reconstruction strategies for valvular assessment and discusses CT-based evaluations of native-valve stenosis and regurgitation, prosthetic-valve dysfunction-including structural degeneration, thrombosis, and pannus-and infective endocarditis, highlighting the complementary role of CT alongside echocardiography in comprehensive VHD management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.